³µ¶Áõ Ä¡·á ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : À¯Çüº°, Ä¡·á À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Dyslexia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Phonological Dyslexia, Surface Dyslexia, and Others); By Therapy Type; By End User; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå
:
1423936
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 114 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ³µ¶Áõ Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 549¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
³µ¶ÁõÀÌ Æ¯Á¤ ÇнÀ Àå¾Ö¶ó´Â ÀνÄÀÌ ³ô¾ÆÁö°í ³µ¶Áõ ¾Æµ¿¿¡ ´ëÇÑ Á¶±â °³ÀÔÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ³µ¶ÁõÀ» Á¶±â¿¡ ¹ß°ßÇϱâ À§ÇÑ ÀÇ·á ¼ºñ½º Á¦°ø¾÷üÀÇ ³ë·ÂÀÌ ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼°è ÁÖ¿ä ÇコÄÉ¾î ±â¾÷µéÀÌ ³µ¶Áõ Ä¡·á¸¦ À§ÇÑ »õ·Î¿î ÀáÀçÀû ¿ëµµ¸¦ °³¹ßÇϱâ À§ÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸¸ç, ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼ ³µ¶Áõ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ƯÁ¤ Áø´ÜÀ²ÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ´Â °Íµµ ¼ö³â°£ ½ÃÀå ¼ö¿ä¿Í ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
¿¹¸¦ µé¾î, 2022³â 1¿ù, ¿ù½Ã´ëÇÐÀº ¿ÀÇÏÀÌ¿ÀÁÖ Çб³¸¦ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ »õ·Î¿î '³µ¶Áõ Ä¡·á ¼®»ç' ÇÐÀ§¸¦ µµÀÔÇÏ¿© ³µ¶ÁõÀ¸·Î °íÅë¹Þ´Â ¾î¸°À̵鿡°Ô ¼ºñ½º¿Í °ËÁøÀ» Á¦°øÇÒ ¿¹Á¤ÀÔ´Ï´Ù.
Çб³¿Í ±³À°±â°üÀº ³µ¶Áõ ¾Æµ¿À» Á¶±â¿¡ ¹ß°ßÇϰí Áö¿øÇϱâ À§ÇØ Áõ°Å¿¡ ±â¹ÝÇÑ Àü·«À» äÅÃÇϰí ÀÖÀ¸¸ç, ³µ¶Áõ Á¶±â °³ÀÔ¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.
Áö³ ¸î ³âµ¿¾È ³µ¶Áõ ȯÀÚÀÇ Àб⠴ɷ Çâ»óÀ» µ½±â À§ÇØ ´Ù¾çÇÑ ¼ÒÇÁÆ®¿þ¾î ÇÁ·Î±×·¥°ú ¿ëµµÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ³µ¶Áõ ȯÀÚµéÀÌ ½±°Ô ÀÐÀ» ¼ö ÀÖµµ·Ï Àü ¼¼°èÀûÀ¸·Î ´Ù¾çÇÑ Æ¯¼ö ±Û²Ã°ú ¼Ã¼°¡ µðÀÚÀεǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±Û²ÃÀº ±ÛÀÚ¿Í ´Ü¾î »çÀÌÀÇ È¥¶õÀ» ÁÙÀÌ°í ±ÛÀÚ¿Í ±ÛÀÚ »çÀ̸¦ ¼öÁ¤ÇÏ¿© °³Àο¡°Ô µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ³µ¶Áõ Æò°¡ ¹× Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ´Â ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý Ä¡·á ¼ºñ½ºÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
³µ¶Áõ Ä¡·á ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
À½¿î ³µ¶Áõ ºÎ¹®Àº Çõ½ÅÀûÀ̰í Á¤È®ÇÑ Áø´ÜÀÌ °¡´ÉÇÏ´Ù´Â ÀνÄÀÌ È®»êµÇ¸é¼ ½ÃÀå Á¡À¯À²ÀÌ µÎµå·¯Áö°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
ÀÛ¾÷Ä¡·á ºÎ¹®ÀÌ ¸ÅÃâÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϸç, Ä¡·á¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±ÙÀ¸·Î È®»êµÇ°í ÀÖ½À´Ï´Ù.
ÀçÅÃÀÇ·á ºÎ¹®Àº º¸´Ù Æí¾ÈÇϰí Ä£±ÙÇÑ Ä¡·á¹ýÀ̶ó´Â ÀÌÀ¯·Î ÀçÅÃÀǷḦ ¼±È£Çϴ ȯÀÚ°¡ ±ÞÁõÇÏ¸é¼ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹Ì´Â ÀÇ·áºñ ÁöÃâ°ú Á¤ºÎ ¹ý·üÀÌ Àß Á¤ºñµÇ¾î ÀÖ¾î ¼¼°è ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷Àº Kurzwell Education, Cogmed, Eli Lilly & Company, Jubiliant Pharma Limited, Pearson PLC, Pfizer Inc, Teva Pharmaceutical µîÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ ³µ¶Áõ Ä¡·á ½ÃÀå ÀλçÀÌÆ®
³µ¶Áõ Ä¡·á ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚ ÇöȲ
³µ¶Áõ Ä¡·á ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
PESTEL ºÐ¼®
³µ¶Áõ Ä¡·á ½ÃÀå ÃÖÁ¾»ç¿ëÀÚ µ¿Çâ
¹ë·ùüÀÎ ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ ³µ¶Áõ Ä¡·á ½ÃÀå, À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
À½¿î¼º ³µ¶Áõ
Ç¥Ãþ¼º ³µ¶Áõ
±âŸ
Á¦6Àå ¼¼°èÀÇ ³µ¶Áõ Ä¡·á ½ÃÀå, Ä¡·áº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
ÀÛ¾÷ Ä¡·á
¾ð¾î Ä¡·á
ÀÎÁö Çൿ Ä¡·á
Á¦7Àå ¼¼°èÀÇ ³µ¶Áõ Ä¡·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
Àü¹®¼¾ÅÍ
ÀçÅÃÄ¡·á
º´¿ø ¹× Áø·á¼Ò
±âŸ
Á¦8Àå ¼¼°èÀÇ ³µ¶Áõ Ä¡·á ½ÃÀå, Áö¿ªº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
³µ¶Áõ Ä¡·á ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
³µ¶Áõ Ä¡·á ½ÃÀå - ºÏ¹Ì
ºÏ¹Ì : ³µ¶Áõ Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
ºÏ¹Ì : ³µ¶Áõ Ä¡·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
ºÏ¹Ì : ³µ¶Áõ Ä¡·á ½ÃÀå, Ä¡·á À¯Çüº°, 2019-2032³â
³µ¶Áõ Ä¡·á ½ÃÀå - ¹Ì±¹
³µ¶Áõ Ä¡·á ½ÃÀå - ij³ª´Ù
³µ¶Áõ Ä¡·á ½ÃÀå - À¯·´
À¯·´ : ³µ¶Áõ Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
À¯·´ : ³µ¶Áõ Ä¡·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
À¯·´ : ³µ¶Áõ Ä¡·á ½ÃÀå, Ä¡·á À¯Çüº°, 2019-2032³â
³µ¶Áõ Ä¡·á ½ÃÀå - ¿µ±¹
³µ¶Áõ Ä¡·á ½ÃÀå - ÇÁ¶û½º
³µ¶Áõ Ä¡·á ½ÃÀå - µ¶ÀÏ
³µ¶Áõ Ä¡·á ½ÃÀå - ÀÌÅ»¸®¾Æ
³µ¶Áõ Ä¡·á ½ÃÀå - ½ºÆäÀÎ
³µ¶Áõ Ä¡·á ½ÃÀå - ³×´ú¶õµå
³µ¶Áõ Ä¡·á ½ÃÀå - ·¯½Ã¾Æ
³µ¶Áõ Ä¡·á ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : ³µ¶Áõ Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : ³µ¶Áõ Ä¡·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : ³µ¶Áõ Ä¡·á ½ÃÀå, Ä¡·á À¯Çüº°, 2019-2032³â
³µ¶Áõ Ä¡·á ½ÃÀå - Áß±¹
³µ¶Áõ Ä¡·á ½ÃÀå - Àεµ
³µ¶Áõ Ä¡·á ½ÃÀå - ¸»·¹À̽þÆ
³µ¶Áõ Ä¡·á ½ÃÀå - ÀϺ»
³µ¶Áõ Ä¡·á ½ÃÀå - Àεµ³×½Ã¾Æ
³µ¶Áõ Ä¡·á ½ÃÀå - Çѱ¹
³µ¶Áõ Ä¡·á ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ³µ¶Áõ Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ³µ¶Áõ Ä¡·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ³µ¶Áõ Ä¡·á ½ÃÀå, Ä¡·á À¯Çüº°, 2019-2032³â
³µ¶Áõ Ä¡·á ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
³µ¶Áõ Ä¡·á ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
³µ¶Áõ Ä¡·á ½ÃÀå - À̽º¶ó¿¤
³µ¶Áõ Ä¡·á ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
³µ¶Áõ Ä¡·á ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : ³µ¶Áõ Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ³µ¶Áõ Ä¡·á ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ³µ¶Áõ Ä¡·á ½ÃÀå, Ä¡·á À¯Çüº°, 2019-2032³â
³µ¶Áõ Ä¡·á ½ÃÀå - ¸ß½ÃÄÚ
³µ¶Áõ Ä¡·á ½ÃÀå - ºê¶óÁú
³µ¶Áõ Ä¡·á ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦9Àå °æÀï ±¸µµ
È®Àå ¹× Àμö ºÐ¼®
Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦10Àå ±â¾÷ °³¿ä
Cogmed
CogniFit
Dyslexia Action Group Holdings Ltd.
Eli Lilly & Company
Gemm Learning
Jubiliant Pharma Limited
Kurzweil Education
Lindamood Bell
Lyfta
Nessy Learning LLC
NeuroNet Learning
Novartis AG
Pearson PLC
Pfizer Inc.
RPG Lifesciences
Scientific Learning Corporation
Teva Pharmaceutical Industries
LSH
¿µ¹® ¸ñÂ÷
The global dyslexia treatment market size is expected to reach USD 54.90 billion by 2032, according to a new study by Polaris Market Research. The report "Dyslexia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Phonological Dyslexia, Surface Dyslexia, and Others); By Therapy Type; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Growing awareness of dyslexia as a specific learning disability and increasing recognition of the importance of early intervention for children with dyslexia along with the focus of healthcare providers on identifying dyslexia in its early stages, are primary factors driving the growth of the global market. Growing efforts to develop new potential applications to cure dyslexia by major healthcare companies worldwide and continuous growth in the specific diagnostic rate particularly in emerging economies, as they are becoming more aware of dyslexia, has also been driving the market demand and growth over the years.
For instance, in January 2022, Walsh University, introduced new "Master of Dyslexia Therapy" degree, which is especially designed to address Ohio school, to provide services & screening for children suffering with the dyslexia.
There is a growing emphasis on early intervention for dyslexia with schools and educational institutions increasingly adopting evidence-based strategies to identify and support children with dyslexia at an early age, and could generate huge growth potential for the market.
Various software programs and applications have been developed in the last few years to help individuals with dyslexia improve their reading skills, as these programs use interactive exercises and games to engage users and provide personalized instruction. Besides this, various special fonts and typefaces have been designed across the globe with a focus on making reading easier for dyslexic individuals because these fonts feature modified characters and spacing to reduce confusion between letters and words and help individuals.
Furthermore, there has been a rising adoption of telehealth and teletherapy services that have expanded access to dyslexia assessment and treatment, as it provides significant opportunities for companies to reach individuals in underserved areas and allows for more flexible and convenient care delivery.
Dyslexia Treatment Market Report Highlights
The phonological dyslexia segment accounted for a notable market share, mainly due to increasing awareness among people about the availability of innovative, accurate diagnosis
The occupational therapy segment held the majority revenue share, its rising proliferation drives as a holistic approach to treatment
The home care segment will grow at the highest growth rate on account of a surge in the number of patients preferring home care due to its higher comfort and familiar treatment
North America dominated the global market with substantial share, owing to the region's well-developed healthcare expenditure and supportive government laws
The key market players include Kurzwell Education, Cogmed, Eli Lilly & Company, Jubiliant Pharma Limited, Pearson PLC, Pfizer Inc., and Teva Pharmaceutical
Polaris Market Research has segmented the dyslexia treatment market report based on type, therapy type, end user, and region:
Dyslexia Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)
Phonological Dyslexia
Surface Dyslexia
Others
Dyslexia Treatment, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)
Occupational Therapy
Speech Therapy
Cognitive Behavioural Therapy
Dyslexia Treatment, End User Outlook (Revenue - USD Billion, 2019 - 2032)
Specialty Center
Home Care
Hospitals and Clinics
Others
Dyslexia Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Dyslexia Treatment Market Insights
4.1. Dyslexia Treatment Market - End User Snapshot
4.2. Dyslexia Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Development of virtual reality-based educational software and growing incidences of dyslexia
4.2.1.2. Increasing awareness and early diagnosis
4.2.2. Restraints and Challenges
4.2.2.1. Stigma and social perception
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Dyslexia Treatment Market End User Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Dyslexia Treatment Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
5.3. Phonological Dyslexia
5.3.1. Global Dyslexia Treatment Market, by Phonological Dyslexia, by Region, 2019-2032 (USD Billion)
5.4. Surface Dyslexia
5.4.1. Global Dyslexia Treatment Market, by Surface Dyslexia, by Region, 2019-2032 (USD Billion)
5.5. Others
5.5.1. Global Dyslexia Treatment Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Dyslexia Treatment Market, by Therapy Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
6.3. Occupational Therapy
6.3.1. Global Dyslexia Treatment Market, by Occupational Therapy, by Region, 2019-2032 (USD Billion)
6.4. Speech Therapy
6.4.1. Global Dyslexia Treatment Market, by Speech Therapy, by Region, 2019-2032 (USD Billion)
6.5. Cognitive Behavioural Therapy
6.5.1. Global Dyslexia Treatment Market, by Cognitive Behavioural Therapy, by Region, 2019-2032 (USD Billion)
7. Global Dyslexia Treatment Market, by End User
7.1. Key Findings
7.2. Introduction
7.2.1. Global Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
7.3. Specialty Center
7.3.1. Global Dyslexia Treatment Market, by Specialty Center, By Region, 2019-2032 (USD Billion)
7.4. Home Care
7.4.1. Global Dyslexia Treatment Market, by Home Care, By Region, 2019-2032 (USD Billion)
7.5. Hospitals and Clinics
7.5.1. Global Dyslexia Treatment Market, by Hospitals and Clinics, By Region, 2019-2032 (USD Billion)
7.6. Others
7.6.1. Global Dyslexia Treatment Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Dyslexia Treatment Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Dyslexia Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Dyslexia Treatment Market - North America
8.3.1. North America: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.3.2. North America: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.3.3. North America: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.3.4. Dyslexia Treatment Market - U.S.
8.3.4.1. U.S.: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.3.4.2. U.S.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.3.4.3. U.S.: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.3.5. Dyslexia Treatment Market - Canada
8.3.5.1. Canada: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.3.5.2. Canada.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.3.5.3. Canada: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4. Dyslexia Treatment Market - Europe
8.4.1. Europe: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.2. Europe.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.3. Europe: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.4. Dyslexia Treatment Market - UK
8.4.4.1. UK: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.4.2. UK.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.4.3. UK: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.5. Dyslexia Treatment Market - France
8.4.5.1. France: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.5.2. France.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.5.3. France: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.6. Dyslexia Treatment Market - Germany
8.4.6.1. Germany: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.6.2. Germany.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.6.3. Germany: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.7. Dyslexia Treatment Market - Italy
8.4.7.1. Italy: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.7.2. Italy.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.7.3. Italy: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.8. Dyslexia Treatment Market - Spain
8.4.8.1. Spain: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.8.2. Spain.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.8.3. Spain: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.9. Dyslexia Treatment Market - Netherlands
8.4.9.1. Netherlands: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.9.2. Netherlands.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.9.3. Netherlands: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.4.10. Dyslexia Treatment Market - Russia
8.4.10.1. Russia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.4.10.2. Russia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.4.10.3. Russia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5. Dyslexia Treatment Market - Asia Pacific
8.5.1. Asia Pacific: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.2. Asia Pacific.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.3. Asia Pacific: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5.4. Dyslexia Treatment Market - China
8.5.4.1. China: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.4.2. China.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.4.3. China: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5.5. Dyslexia Treatment Market - India
8.5.5.1. India: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.5.2. India.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.5.3. India: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5.6. Dyslexia Treatment Market - Malaysia
8.5.6.1. Malaysia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.6.2. Malaysia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.6.3. Malaysia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5.7. Dyslexia Treatment Market - Japan
8.5.7.1. Japan: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.7.2. Japan.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.7.3. Japan: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5.8. Dyslexia Treatment Market - Indonesia
8.5.8.1. Indonesia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.8.2. Indonesia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.8.3. Indonesia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.5.9. Dyslexia Treatment Market - South Korea
8.5.9.1. South Korea: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.5.9.2. South Korea.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.5.9.3. South Korea: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.6. Dyslexia Treatment Market - Middle East & Africa
8.6.1. Middle East & Africa: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.6.2. Middle East & Africa.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.6.3. Middle East & Africa: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.6.4. Dyslexia Treatment Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.6.4.2. Saudi Arabia.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.6.4.3. Saudi Arabia: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.6.5. Dyslexia Treatment Market - UAE
8.6.5.1. UAE: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.6.5.2. UAE.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.6.5.3. UAE: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.6.6. Dyslexia Treatment Market - Israel
8.6.6.1. Israel: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.6.6.2. Israel.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.6.6.3. Israel: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.6.7. Dyslexia Treatment Market - South Africa
8.6.7.1. South Africa: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.6.7.2. South Africa.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.6.7.3. South Africa: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.7. Dyslexia Treatment Market - Latin America
8.7.1. Latin America: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.7.2. Latin America.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.7.3. Latin America: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.7.4. Dyslexia Treatment Market - Mexico
8.7.4.1. Mexico: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.7.4.2. Mexico.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.7.4.3. Mexico: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.7.5. Dyslexia Treatment Market - Brazil
8.7.5.1. Brazil: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.7.5.2. Brazil.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.7.5.3. Brazil: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
8.7.6. Dyslexia Treatment Market - Argentina
8.7.6.1. Argentina: Dyslexia Treatment Market, by Type, 2019-2032 (USD Billion)
8.7.6.2. Argentina.: Dyslexia Treatment Market, by End User, 2019-2032 (USD Billion)
8.7.6.3. Argentina: Dyslexia Treatment Market, by Therapy Type, 2019-2032 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Cogmed
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. CogniFit
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Dyslexia Action Group Holdings Ltd.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Eli Lilly & Company
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Gemm Learning
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Jubiliant Pharma Limited
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Kurzweil Education
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Lindamood Bell
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Lyfta
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Nessy Learning LLC
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. NeuroNet Learning
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Novartis AG
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Pearson PLC
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. Pfizer Inc.
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. RPG Lifesciences
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Scientific Learning Corporation
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development
10.17. Teva Pharmaceutical Industries
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Recent Development
°ü·ÃÀÚ·á